Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
This page is not indexed by search engines while we improve data quality.
BioNTech SE — Physics
BioNTech SE holds 43 patents in Physics, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | BioNTech SE |
| Technology | Physics |
| Patents in slice | 43 |
| Recent patents in slice | 25 |
| First year | 2020 |
| Last year | 2026 |
Representative patents
Notable publications linking BioNTech SE to Physics.
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Recent filings
Latest patents from BioNTech SE in Physics.
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Tumor Antigens for Determining Cancer Therapy
US-2026049112-A1 · Feb 19, 2026 · US
Related pages
Navigate to parent entity pages.